Verastem closes $16 million Series A financing

[News]

Verastem, Inc., a biopharmaceutical company focused on discovering and developing drugs to treat cancer by targeting cancer stem cells, today announced the closing of a $16 million Series A financing. Founding investor, Longwood Founders Fund, was joined by Bessemer Venture Partners, Cardinal Partners, and MPM Capital.

More... (http://www.news-medical.net/news/20101116/Verastem-closes-2416-million-Series-A-financing.aspx)